Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02259621
Title Neoadjuvant Anti-PD-1, Nivolumab in Resectable NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sidney Kimmel Comprehensive Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Johns Hopkins at Bayview Medical Center Recruiting Baltimore Maryland 21224 United States Details
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore Maryland 21287 United States Details
Memorial Sloan Kettering Recruiting New York New York 10065 United States Details
Swedish Cancer Insitute Recruiting Edmonds Washington 98026 United States Details
Johnathan Spicer Recruiting Montréal Quebec H4 3J1 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field